These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 19774597

  • 1. Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica.
    Di Pasqua AJ, Wallner S, Kerwood DJ, Dabrowiak JC.
    Chem Biodivers; 2009 Sep; 6(9):1343-9. PubMed ID: 19774597
    [Abstract] [Full Text] [Related]

  • 2. Activation of carboplatin by carbonate.
    Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC.
    Chem Res Toxicol; 2006 Jan; 19(1):139-49. PubMed ID: 16411667
    [Abstract] [Full Text] [Related]

  • 3. Role of carbonate in the cytotoxicity of carboplatin.
    Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dubowy RL, Dabrowiak JC.
    Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
    [Abstract] [Full Text] [Related]

  • 4. Modification of carboplatin by Jurkat cells.
    Di Pasqua AJ, Goodisman J, Kerwood DJ, Toms BB, Dabrowiak JC.
    J Inorg Biochem; 2007 Oct; 101(10):1438-41. PubMed ID: 17655933
    [Abstract] [Full Text] [Related]

  • 5. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles.
    Tao Z, Xie Y, Goodisman J, Asefa T.
    Langmuir; 2010 Jun 01; 26(11):8914-24. PubMed ID: 20148511
    [Abstract] [Full Text] [Related]

  • 6. Comparison of different theory models and basis sets in the calculations of structures and 13C NMR spectra of [Pt(en)(CBDCA-O, O')], an analogue of the antitumor drug carboplatin.
    Gao H, Wei X, Liu X, Yan T.
    J Phys Chem B; 2010 Mar 25; 114(11):4056-62. PubMed ID: 20199040
    [Abstract] [Full Text] [Related]

  • 7. NMR study of the adsorption-desorption kinetics of dissolved tetraalanine in MCM-41 mesoporous material.
    Pizzanelli S, Kababya S, Frydman V, Landau M, Vega S.
    J Phys Chem B; 2005 Apr 28; 109(16):8029-39. PubMed ID: 16851938
    [Abstract] [Full Text] [Related]

  • 8. Kinetic study on the reactions of platinum drugs with glutathione.
    Hagrman D, Goodisman J, Souid AK.
    J Pharmacol Exp Ther; 2004 Feb 28; 308(2):658-66. PubMed ID: 14610218
    [Abstract] [Full Text] [Related]

  • 9. 2-Mercaptothiazoline modified mesoporous silica for mercury removal from aqueous media.
    Pérez-Quintanilla D, del Hierro I, Fajardo M, Sierra I.
    J Hazard Mater; 2006 Jun 30; 134(1-3):245-56. PubMed ID: 16326000
    [Abstract] [Full Text] [Related]

  • 10. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
    Tao Z, Toms B, Goodisman J, Asefa T.
    ACS Nano; 2010 Feb 23; 4(2):789-94. PubMed ID: 20131868
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W, Chen X, Xie M, Lou L, Ye Q, Yu Y, Hou S.
    J Inorg Biochem; 2008 Oct 23; 102(10):1942-6. PubMed ID: 18707762
    [Abstract] [Full Text] [Related]

  • 12. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
    Becker M, Port RE, Zabel HJ, Zeller WJ, Bachert P.
    J Magn Reson; 1998 Jul 23; 133(1):115-22. PubMed ID: 9654475
    [Abstract] [Full Text] [Related]

  • 13. Effective controlled release of captopril by silylation of mesoporous MCM-41.
    Qu F, Zhu G, Huang S, Li S, Qiu S.
    Chemphyschem; 2006 Feb 13; 7(2):400-6. PubMed ID: 16411260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesoporous silica material TUD-1 as a drug delivery system.
    Heikkilä T, Salonen J, Tuura J, Hamdy MS, Mul G, Kumar N, Salmi T, Murzin DY, Laitinen L, Kaukonen AM, Hirvonen J, Lehto VP.
    Int J Pharm; 2007 Feb 22; 331(1):133-8. PubMed ID: 17046183
    [Abstract] [Full Text] [Related]

  • 16. pH-responsive controlled release of antitumour-active polyoxometalate from mesoporous silica materials.
    Sun G, Chang Y, Li S, Li Q, Xu R, Gu J, Wang E.
    Dalton Trans; 2009 Jun 21; (23):4481-7. PubMed ID: 19488446
    [Abstract] [Full Text] [Related]

  • 17. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.
    Di Pasqua AJ, Centerwall CR, Kerwood DJ, Dabrowiak JC.
    Inorg Chem; 2009 Feb 02; 48(3):1192-7. PubMed ID: 19113934
    [Abstract] [Full Text] [Related]

  • 18. Hydrogen bonding of water confined in mesoporous silica MCM-41 and SBA-15 studied by 1H solid-state NMR.
    Grünberg B, Emmler T, Gedat E, Shenderovich I, Findenegg GH, Limbach HH, Buntkowsky G.
    Chemistry; 2004 Nov 05; 10(22):5689-96. PubMed ID: 15470692
    [Abstract] [Full Text] [Related]

  • 19. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V, Perioli L, Marmottini F, Giovagnoli S, Esposito M, Rossi C.
    Eur J Pharm Sci; 2007 Nov 05; 32(3):216-22. PubMed ID: 17826966
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization, and Zn(2+) adsorption behavior of chemically modified MCM-41 with 5-mercapto-1-methyltetrazole.
    Pérez-Quintanilla D, Sánchez A, del Hierro I, Fajardo M, Sierra I.
    J Colloid Interface Sci; 2007 Sep 15; 313(2):551-62. PubMed ID: 17532331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.